Department of Stem Cell Sciences, Hacettepe University Graduate School of Health Sciences, Ankara, Sihhiye, Turkey.
Center for Stem Cell Research and Development, Hacettepe University, Ankara, Sihhiye, Turkey.
J Cell Biochem. 2022 Feb;123(2):406-416. doi: 10.1002/jcb.30180. Epub 2021 Nov 15.
Intracellular and extracellular regulatory factors promote the potency and self-renewal property of stem cells. Methionine is fundamental for protein synthesis and regulation of methylation reactions. Specifically, methionine metabolism in embryonic and fetal development processes regulates gene expression profile/epigenetic identity of stem cells to achieve pluripotency and cellular functions. We aimed to reveal the differences in methionine metabolism of bone marrow (BM)-mesenchymal stem cells (MSCs), umbilical cord blood (UCB)-MSCs, and cancer stem cells (CSCs), which reflect different metabolic profiles and developmental stages of stem cells. UCB-MSC, BM-MSCs, and breast CSCs were treated with different doses (0, 10, 25, 50, and 100 µM) of l-methionine. Cell surface marker and cell cycle assessment were performed by flow cytometry. Changes in gene expressions (OCT3/4, NANOG, DMNT1, DNMT3A, and DNMT3B, MAT2A, and MAT2B) with methionine supplementation were examined by quantitative real-time polymerase chain reaction and the changes in histone methylation (H3K4me3, H3K27me3) levels were demonstrated by western blot analysis. S-adenosylmethionine//S-adenosylhomocysteine (SAM/SAH) levels were evaluated by enzyme-linked immunosorbent assay. Cells that were exposed to different concentrations of l-methionine, were mostly arrested in the G0/G1 phase for each stem cell group. It was evaluated that BM-MSCs increased all gene expressions in the culture medium-containing 100 µM methionine, in addition to SAM/SAH levels. On the other hand, UCB-MSCs were found to increase OCT3/4, NANOG, and DNMT1 gene expressions and decrease MAT2A and MAT2B expressions in the culture medium containing 10 µM methionine. Moreover, an increase was observed in the He3K4me3 methylation profile. In addition, OCT3/4, NANOG, DNMT1, and MAT2B gene expressions in CSCs increased starting from the addition of 25 µM methionine. An increase was determined in H3K4me3 protein expression at 50 and 100 µM methionine-supplemented culture condition. This study demonstrates that methionine plays a critical role in metabolism and epigenetic regulation in different stem cell groups.
细胞内和细胞外调节因子促进干细胞的效力和自我更新特性。蛋氨酸是蛋白质合成和甲基化反应调节的基础。具体而言,胚胎和胎儿发育过程中的蛋氨酸代谢调节干细胞的基因表达谱/表观遗传特征,以实现多能性和细胞功能。我们旨在揭示骨髓(BM)间充质干细胞(MSC)、脐血(UCB)MSC 和癌症干细胞(CSC)之间蛋氨酸代谢的差异,这反映了干细胞不同的代谢特征和发育阶段。用不同剂量(0、10、25、50 和 100 μM)的 L-蛋氨酸处理 UCB-MSC、BM-MSCs 和乳腺 CSC。通过流式细胞术评估细胞表面标志物和细胞周期。通过定量实时聚合酶链反应检查补充蛋氨酸后基因表达(OCT3/4、NANOG、DMNT1、DNMT3A 和 DNMT3B、MAT2A 和 MAT2B)的变化,并通过 Western blot 分析显示组蛋白甲基化(H3K4me3、H3K27me3)水平的变化。通过酶联免疫吸附试验评估 S-腺苷甲硫氨酸/S-腺苷同型半胱氨酸(SAM/SAH)水平。暴露于不同浓度 L-蛋氨酸的细胞在每种干细胞组的培养基中主要停滞在 G0/G1 期。评估结果表明,BM-MSCs 在含有 100 μM 蛋氨酸的培养基中增加了所有基因的表达,同时增加了 SAM/SAH 水平。另一方面,UCB-MSCs 发现,在含有 10 μM 蛋氨酸的培养基中,OCT3/4、NANOG 和 DNMT1 基因表达增加,MAT2A 和 MAT2B 表达减少。此外,观察到 He3K4me3 甲基化谱的增加。此外,CSC 中的 OCT3/4、NANOG、DNMT1 和 MAT2B 基因表达从添加 25 μM 蛋氨酸开始增加。在添加 50 和 100 μM 蛋氨酸的培养条件下,确定 H3K4me3 蛋白表达增加。本研究表明,蛋氨酸在不同的干细胞群的代谢和表观遗传调节中起着关键作用。